149 related articles for article (PubMed ID: 11109245)
41. A combined analysis of 2 randomized clinical studies of tretinoin gel 0.05% for the treatment of acne.
Webster G; Cargill DI; Quiring J; Vogelson CT; Slade HB
Cutis; 2009 Mar; 83(3):146-54. PubMed ID: 19363908
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life.
Grosshans E; Marks R; Mascaro JM; Torras H; Meynadier J; Alirezai M; Finlay AY; Soto P; Poncet M; Verschoore M; Clucas A
Br J Dermatol; 1998 Oct; 139 Suppl 52():26-33. PubMed ID: 9990418
[TBL] [Abstract][Full Text] [Related]
43. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris.
Cambazard F
J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S20-7; discussion S28-9. PubMed ID: 9891905
[TBL] [Abstract][Full Text] [Related]
44. A comparative evaluation of tretinoin gel microsphere, 0.1%, versus tretinoin cream, 0.025%, in reducing facial shine.
Nyirady J; Nighland M; Payonk G; Pote J; Phillips S; Grossman R
Cutis; 2000 Aug; 66(2):153-6. PubMed ID: 10955199
[TBL] [Abstract][Full Text] [Related]
45. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.
Kircik LH; Baldwin H; Lain E; Guenin E; Harris S; Bhatt V
J Drugs Dermatol; 2019 Feb; 18(2):178-188. PubMed ID: 30811141
[TBL] [Abstract][Full Text] [Related]
46. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin.
Ridolfi DM; Marcato PD; Justo GZ; Cordi L; Machado D; Durán N
Colloids Surf B Biointerfaces; 2012 May; 93():36-40. PubMed ID: 22244299
[TBL] [Abstract][Full Text] [Related]
47. Intradermal and follicular delivery of adapalene liposomes.
Kumar V; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
[TBL] [Abstract][Full Text] [Related]
48. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V
J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791
[TBL] [Abstract][Full Text] [Related]
49. Evaluating tretinoin formulations in the treatment of acne.
Kircik LH
J Drugs Dermatol; 2014 Apr; 13(4):466-70. PubMed ID: 24719067
[TBL] [Abstract][Full Text] [Related]
50. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin.
Katsambas A; Graupe K; Stratigos J
Acta Derm Venereol Suppl (Stockh); 1989; 143():35-9. PubMed ID: 2528257
[TBL] [Abstract][Full Text] [Related]
51. Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen.
Pariser D; Bucko A; Fried R; Jarratt MT; Kempers S; Kircik L; Lucky AW; Rafal E; Rendon M; Weiss J; Wilson DC; Rossi AB; Ramaswamy R; Nighland M
J Drugs Dermatol; 2010 Jul; 9(7):805-13. PubMed ID: 20677537
[TBL] [Abstract][Full Text] [Related]
52. Topical vitamin A acid in acne vulgaris.
Juhlin L
Acta Derm Venereol Suppl (Stockh); 1975 Jan 27-29; 74():133-4. PubMed ID: 130776
[TBL] [Abstract][Full Text] [Related]
53. Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation.
Kumar R; Singh B; Bakshi G; Katare OP
Pharm Dev Technol; 2007; 12(6):591-601. PubMed ID: 18161632
[TBL] [Abstract][Full Text] [Related]
54. Tretinoin microsphere gel in younger acne patients.
Jorizzo J; Grossman R; Nighland M
J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s9-13. PubMed ID: 18724649
[TBL] [Abstract][Full Text] [Related]
55. A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years.
Eichenfield LF; Wortzman M
Pediatr Dermatol; 2009; 26(3):257-61. PubMed ID: 19706084
[TBL] [Abstract][Full Text] [Related]
56. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis.
Gupta M; Goyal AK; Paliwal SR; Paliwal R; Mishra N; Vaidya B; Dube D; Jain SK; Vyas SP
J Liposome Res; 2010 Dec; 20(4):341-50. PubMed ID: 20163329
[TBL] [Abstract][Full Text] [Related]
57. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Draelos ZD; Potts A; Alió Saenz AB;
Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
[TBL] [Abstract][Full Text] [Related]
58. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris.
Domínguez J; Hojyo MT; Celayo JL; Domínguez-Soto L; Teixeira F
Int J Dermatol; 1998 Jan; 37(1):54-5. PubMed ID: 9522243
[TBL] [Abstract][Full Text] [Related]
59. Tretinoin microsphere gel in facial acne vulgaris: a meta-analysis.
Nighland M; Grossman R
J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s2-8. PubMed ID: 18724648
[TBL] [Abstract][Full Text] [Related]
60. Acne vulgaris: treatment with topical benzoyl peroxide acetone gel.
Montes LF
Cutis; 1977 May; 19(5):681-5. PubMed ID: 140786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
